31 results on '"Mycka, J"'
Search Results
2. HPR187 Injectable Oncology Therapies: Benchmarking Gross and Net Price Differentials in Europe vs US.
3. HPR149 Global Pricing, Reimbursement and Market Access Trends for Regenerative Medicines, ATMPs, Cell, & Gene Therapies
4. HPR26 Pricing, Reimbursement and Market Access Trends for Cell and Gene Therapies in the US and Europe
5. HPR10 Cell and Gene Therapy Access in the US and European Countries
6. P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective
7. PNS90 PROPOSED US INTERNATIONAL REFERENCE PRICING, POSSIBLE IMPACT
8. PMU54 A 10-YEAR REVIEW (2009-2018) OF MARKET ACCESS OF PHARMACEUTICALS IN THE EU5 AND US
9. PNS85 MARKET ACCESS TRENDS ACROSS THE EU5 AND US: 2009 TO 2018- AN UPDATE
10. PHP229 - EU5 MARKET ACCESS FOR MEDICINES WITH CONDITIONAL MARKETING AUTHORISATIONS
11. PSY166 - MARKET ACCESS TRENDS FOR ADVANCED THERAPY MEDICINAL PRODUCTS (ATMPS) IN EUROPE
12. PHP230 - EU5 MARKET ACCESS FOR MEDICINES APPROVED UNDER EXCEPTIONAL CIRCUMSTANCES
13. Market Access Trends Across The EU5: 2009 To 2016- An Update
14. Advanced Therapy Medicinal Products (Atmps) In Europe 8 Years On: What Is The Path To Market Access So Far?
15. MARKET ACCESS TRENDS ACROSS THE EU5: 2010 TO 2015
16. REGULATORY APPROVAL TO PATIENT ACCESS: AN EVALUATION OF EU5 AND US NATIONAL TIMING DIFFERENCES - AN UPDATE (2009–2015)
17. Orphan Drugs Assessment in Germany: A Comparison with Other International HTA Agencies
18. Timing of eu5 & US Orphan Drug approvals and PRMA between 2009 and 2013
19. A foundation for real recursive function theory
20. PHP147 - Market Access Trends Across The EU5: 2009 To 2016- An Update
21. Regulatory Approval To Patient Access, An Evaluation of Eu5 And Us National Timing Differences: An Update
22. PHP222 - Advanced Therapy Medicinal Products (Atmps) In Europe 8 Years On: What Is The Path To Market Access So Far?
23. PHP140 - MARKET ACCESS TRENDS ACROSS THE EU5: 2010 TO 2015
24. PHP139 - REGULATORY APPROVAL TO PATIENT ACCESS: AN EVALUATION OF EU5 AND US NATIONAL TIMING DIFFERENCES - AN UPDATE (2009–2015)
25. PSY77 - Timing of eu5 & US Orphan Drug approvals and PRMA between 2009 and 2013
26. Undecidability over Continuous Time
27. PHP56 - Regulatory Approval to Patient Access, an Evaluation of EU5 and us National Timing Differences
28. PHP211 - Orphan Drugs Assessment in Germany: A Comparison with Other International HTA Agencies
29. The euclid abstract machine: Trisection of the angle and the halting problem
30. The Euclid abstract machine
31. The computational power of continuous dynamic systems
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.